Go Pro
OTCMKTS:PTNT

Palatin Technologies (PTNT) Stock Price, News & Analysis

Palatin Technologies logo
$24.12 +0.02 (+0.08%)
As of 07/31/2026 04:10 PM Eastern

About Palatin Technologies Stock (OTCMKTS:PTNT)

Advanced

Key Stats

Today's Range
$24.12
$24.12
50-Day Range
$23.90
$28.06
52-Week Range
$23.90
$28.06
Volume
18 shs
Average Volume
1,297 shs
Market Capitalization
$964.80 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that is in Phase 2 clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease, which is in Phase 3 clinical trial; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL8177, an oral peptide formulation for treatment of ulcerative colitis, which entered Phase 2 clinical trials. The company was founded in 1986 and is based in Cranbury, New Jersey.

Receive PTNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Palatin Technologies and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PTNT Stock News Headlines

Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel
See More Headlines

PTNT Stock Analysis - Frequently Asked Questions

Palatin Technologies' stock was trading at $5.60 at the beginning of 2026. Since then, PTNT stock has increased by 330.7% and is now trading at $24.12.

Palatin Technologies, Inc. (OTCMKTS:PTNT) released its earnings results on Wednesday, May, 15th. The biopharmaceutical company reported ($26.50) EPS for the quarter, missing analysts' consensus estimates of ($25.00) by $1.50.
Read the conference call transcript
.

Palatin Technologies shares reverse split before market open on Tuesday, August 12th 2025.The 1-50 reverse split was announced on Tuesday, August 12th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, August 12th 2025. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Shares of PTNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/15/2024
Today
8/01/2026
Fiscal Year End
6/30/2027

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
OTCMKTS:PTNT
Previous Symbol
PINK:PTNT
CIK
911216
Employees
30
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($60.00)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$29.74 million
Net Margins
N/A
Pretax Margin
-1,590.66%
Return on Equity
N/A
Return on Assets
-365.57%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.38
Quick Ratio
0.38

Sales & Book Value

Annual Sales
$4.49 million
Price / Sales
0.21
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.25) per share
Price / Book
-96.48

Miscellaneous

Outstanding Shares
40,000
Free Float
18,160,000
Market Cap
$964.80 thousand
Optionable
Not Optionable
Beta
-1.32
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (OTCMKTS:PTNT) was last updated on 8/1/2026 by MarketBeat.com Staff.
From Our Partners